ClaimGlide
Winter 2026 NewAI automated prior-auths for private medical practices
We automate the entire end-to-end prior-authorization process for private practices for cheaper, and more accurately than they're doing today.
AI Investor Summary
ClaimGlide is an AI-powered solution automating the burdensome prior-authorization process for private medical practices. Led by a founder with a stellar background from Google, Microsoft, and Stanford, the company targets a massive, underserved market with a clear value proposition of cost and accuracy improvement. While the market opportunity is exceptional, early-stage traction and execution by a single founder are key areas to watch.
Key Highlights
- ● Founder's strong technical and business background from Google, Microsoft, and Stanford.
- ● Addresses a massive, universally hated pain point in healthcare with significant market opportunity.
- ● Potential for strong defensibility through AI and data network effects.
Risk Factors
- ● Single founder is a significant risk for execution and scaling.
- ● Lack of demonstrated traction (revenue, users, partnerships) makes it difficult to assess market validation.
- ● Healthcare is a complex, highly regulated industry with long sales cycles and integration challenges.
- ● Competitive landscape, while fragmented, may include established players or other AI startups.
Founders
Nami Lindquist is the co-founder and CEO of ClaimGlide, a Y Combinator startup focused on streamlining insurance claims. Her background combines expertise in technology and a deep understanding of the insurance industry, aiming to improve efficiency and transparency for policyholders. Prior to ClaimGlide, she has a history of working in product and technology roles.
Score Breakdown
Nami Lindquist's background as a former Product Manager at Google and Software Engineer at Microsoft, combined with an MBA from Stanford, demonstrates exceptional technical depth and business acumen. Her experience at top-tier tech companies and prestigious universities suggests a strong ability to execute and build a high-performing team. The single founder is a risk, but her pedigree mitigates it somewhat at this early stage. [Boost +1: Founder from Google]
The prior-authorization market is a massive, persistent pain point in healthcare, with significant TAM and clear growth driven by increasing complexity of treatments and payer rules. Private medical practices are particularly underserved and highly motivated to reduce administrative burden and costs. Regulatory tailwinds around value-based care and administrative simplification could further benefit ClaimGlide. [Boost +0.5: Hot sector: ai]
The core idea of AI-automating prior-authorizations is technically feasible and addresses a clear need. The claim of 'cheaper and more accurately' is a strong differentiator if proven. The defensibility will likely come from proprietary AI models, data network effects, and deep integration into practice workflows. UX quality and platform potential are currently unknown but crucial for adoption.
As a Winter 2026 batch company, traction is expected to be very early. The limited information available suggests minimal revenue or user numbers. Partnerships and significant press coverage are absent, indicating a need for rapid progress in customer acquisition and validation. Investor interest is implied by YC acceptance but not quantified. [Boost +3: Tier-1 VC: accel; Revenue/ARR mentioned]
News
ClaimGlide is a Winter 2026 Y Combinator startup focused on automating the prior authorization process for private medical practices using AI.
ClaimGlide is listed among AI Assistant startups funded by Y Combinator in 2026, focusing on automating prior-authorizations in healthcare.
ClaimGlide is a Winter 2026 Y Combinator startup focused on automating the prior authorization process for private medical practices using AI.
ClaimGlide has raised $500K and offers an AI-driven software solution to automate prior authorization submissions and appeals for specialty medical practices.
ClaimGlide offers end-to-end prior authorization automation for private medical practices, addressing the significant administrative burden and cost associated with this process.
ClaimGlide, founded in 2025, is an unfunded company developing software to automate prior authorization submissions and appeals processes for medical practices.
Claimence has launched an AI platform for financial lines insurance claims, specifically targeting D&O liability claims, aiming to automate and expedite coverage analysis.
ClaimGlide is rated as a C Tier startup by YC Tier List, highlighting its potential in the large prior authorization market but also noting risks associated with a solo founder and competition.
ClaimGlide offers custom AI prior-authorization automation software for private medical practices to increase revenue by getting more prior-auths approved faster.
ClaimGlide is a Y Combinator Winter 2026 startup that automates the prior-authorization process for private medical practices.
Quick Info
- Batch
- Winter 2026
- Team Size
- 1
- Location
- Unspecified
- Founders
- 1
- Scraped
- 4/10/2026